Septoplasty Effective for Nasal Obstruction Linked to Deviated Septum
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
THURSDAY, Oct. 19, 2023 -- For adults with nasal obstruction associated with a deviated nasal septum, septoplasty is a more effective intervention than a defined medical management regimen, according to a study published online Oct. 18 in The BMJ.
Sean Carrie, M.B., Ch.B., from the Newcastle Upon Tyne Hospitals NHS Foundation Trust in the United Kingdom, and colleagues conducted a randomized controlled trial at 17 otolaryngology clinics involving 378 adults newly referred with symptoms of nasal obstruction associated with septal deviation and at least moderate symptoms of nasal obstruction. Participants were randomly assigned to receive septoplasty or defined medical management, including nasal steroid and saline spray for six months (188 and 190 patients, respectively).
The researchers found that the mean Sino-Nasal Outcome Test-22 (SNOT-22) scores at six months were 19.9 and 39.5 in the septoplasty and medical management arms, respectively. Higher baseline symptom severity scores predicted greater improvement in SNOT-22 scores. In participants in the septoplasty group, there was more improvement in quality-of-life outcomes and nasal airflow measures. Seven participants (4 percent) had readmission to hospital with bleeding after septoplasty and 20 participants (12 percent) required antibiotics for infections.
"Baseline Nasal Obstruction and Symptom Evaluation scores can estimate the likely improvement in symptoms and guide decision-making for patients and clinicians," the authors write. "The authors recommend that adults presenting with nasal obstruction associated with a deviated nasal septum should be offered septoplasty."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted October 2023
Read this next
ASCO: Neoadjuvant Ipilimumab + Nivolumab Ups Survival in Resectable Melanoma
WEDNESDAY, June 5, 2024 -- Neoadjuvant ipilimumab plus nivolumab followed by surgery results in longer event-free survival than surgery followed by adjuvant nivolumab among...
Odds of Death Lower With Surgery for Hip Fracture in Patients With Dementia
MONDAY, June 3, 2024 -- For community-dwelling patients with dementia and fracture of the femoral head and neck, the odds of death are lower for those treated surgically...
Emergency Inguinal Hernia Surgery Rates Increased With Lower Country Income
FRIDAY, May 31, 2024 -- For patients undergoing inguinal hernia surgery, emergency surgery rates increase from high- to low-income countries, according to a study published online...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.